Acquired bedaquiline resistance during the treatment of drug-resistant tuberculosis: a systematic review

BACKGROUND: Drug-resistant tuberculosis (DR-TB) is considered to be a public health threat and is difficult to cure, requiring a lengthy treatment with potent, potentially toxic drugs. The novel antimicrobial agent bedaquiline has shown promising results for patients with DR-TB, improving the rate o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallick, Jahan Saeed, Nair, Parvati, Abbew, Elizabeth Tabitha, Van Deun, Armand, Decroo, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963286/
https://www.ncbi.nlm.nih.gov/pubmed/35356403
http://dx.doi.org/10.1093/jacamr/dlac029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963286/
https://www.ncbi.nlm.nih.gov/pubmed/35356403
http://dx.doi.org/10.1093/jacamr/dlac029

Ejemplares similares